Home › Funds › AlpInvest Partners B.V. › CHYM
AlpInvest Partners B.V. position in CHYM
CHIME FINL INC · Financials
AlpInvest Partners B.V. reported holding 249,834 shares of CHYM (CHIME FINL INC) in its Q3 2026 13F filing — a position valued at US$6.7M, representing 8.04% of its reported portfolio and ranking #3 among its reported holdings. AlpInvest Partners B.V. has disclosed CHYM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How AlpInvest Partners B.V.'s CHYM position evolved
AlpInvest Partners B.V. first disclosed a stake in CHYM in Q4 2025 at 344,273 shares (US$8.7M). Across 4 filings, AlpInvest Partners B.V. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 249,834 shares valued at US$6.7M — a reduction of -94,439 shares quarter over quarter.. Notable position changes include a 27% trim in Q3 2026 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 344.27K | $8.67M | New |
| Q1 2026 | 344.27K | $6.45M | Hold |
| Q2 2026 | 344.27K | $7.05M | Hold |
| Q3 2026 | 249.83K | $6.66M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CHYM and 13F data
CHYM (CHIME FINL INC) is a Financials company. 80 other funds we track also report a position in CHYM — the largest reported positions include Galileo (PTC) Ltd (US$959.5M), CROSSLINK CAPITAL INC (US$536.3M), GENERAL ATLANTIC, L.P. (US$435.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CHYM
- Galileo (PTC) Ltd 36.02M sh · $959.54M · Q3 2026
- CROSSLINK CAPITAL INC 26.19M sh · $536.28M · Q2 2026
- GENERAL ATLANTIC, L.P. 21.26M sh · $435.40M · Q2 2026
- Aspect Management, LLC 9.43M sh · $251.35M · Q3 2026
- Menlo Ventures Management, L.P. 8.44M sh · $224.82M · Q3 2026
- Forerunner Ventures Management, LLC 8.03M sh · $164.48M · Q2 2026
- Patient Capital Management, LLC 4.73M sh · $126.03M · Q3 2026
- Tiger Global Management 5.28M sh · $108.22M · Q2 2026
- SOFTBANK GROUP CORP. 5.07M sh · $103.78M · Q2 2026
- Dragoneer Investment Group 4.31M sh · $88.25M · Q2 2026
- Dragoneer Investment Group, LLC 4.31M sh · $88.25M · Q2 2026
- Orland Properties Ltd 3.18M sh · $84.63M · Q3 2026
More on AlpInvest Partners B.V.
FAQ
How long has AlpInvest Partners B.V. held CHYM?
AlpInvest Partners B.V. has disclosed CHYM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is AlpInvest Partners B.V.'s current position in CHYM?
As of Q3 2026, AlpInvest Partners B.V. holds 249.83K shares of CHYM (CHIME FINL INC), valued at $6.66M, representing 8.04% of its reported portfolio and ranking #3.
Has AlpInvest Partners B.V. been buying or selling CHYM?
In the latest 13F filing (Q3 2026), AlpInvest Partners B.V. reduced its position in CHYM.
Which other funds hold CHYM?
Other major institutional holders of CHYM include Galileo (PTC) Ltd, CROSSLINK CAPITAL INC, GENERAL ATLANTIC, L.P., among 80 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.